
Hikal Ltd Hits Intraday Low Amid Price Pressure on 23 Mar 2026
2026-03-23 15:16:00Hikal Ltd experienced significant intraday weakness on 23 Mar 2026, touching a new 52-week low of Rs 156.25, reflecting intense price pressure amid broader sector and market declines. The stock underperformed its Pharmaceuticals & Biotechnology sector peers and the benchmark Sensex, continuing a pronounced downtrend.
Read full news article
Hikal Ltd is Rated Strong Sell
2026-03-23 10:10:30Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low of Rs.165.45 Amid Sector and Market Downturn
2026-03-19 15:40:04Hikal Ltd’s shares declined sharply to a fresh 52-week low of Rs.165.45 on 19 Mar 2026, marking a significant drop amid a broader sector and market downturn. The stock underperformed the Pharmaceuticals & Biotechnology sector, reflecting ongoing pressures on the company’s financial and technical indicators.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low of Rs.166 Amidst Continued Downtrend
2026-03-18 11:10:29Hikal Ltd’s shares touched a fresh 52-week low of Rs.166 today, marking a significant decline amid persistent downward momentum. The stock’s performance over the past year has been notably weak, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low of Rs.169.1 Amidst Continued Downtrend
2026-03-16 10:10:26Hikal Ltd’s share price declined to a fresh 52-week low of Rs.169.1 today, marking a continuation of the stock’s downward trajectory amid broader sector underperformance and persistent financial headwinds.
Read full news article
Hikal Ltd is Rated Strong Sell
2026-03-12 10:10:34Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Hikal Ltd Stock Falls to 52-Week Low of Rs.172.8 Amidst Continued Downtrend
2026-03-09 11:17:14Hikal Ltd’s share price declined sharply to a new 52-week low of Rs.172.8 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s shares have now fallen for six consecutive sessions, cumulatively losing 13.81% over this period, reflecting persistent pressures on the stock amid broader market weakness.
Read full news article
Hikal Ltd is Rated Strong Sell
2026-03-01 10:10:24Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 01 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleClosure of Trading Window
25-Mar-2026 | Source : BSEPursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 please find attached the intimation of the closure of trading window for the quarter and year ending on March 31 2026.
Intimation Under Regulation 7 (2) Of SEBI Prohibition Of Insider Trading Regulations 2015
18-Feb-2026 | Source : BSEIntimation Under Regulation 7 (2) of SEBI Prohibition of Insider Trading Regulations 2015
Disclosure under Regulation 30A of LODR
18-Feb-2026 | Source : BSEIntimation Under regulation 30 and 30A of SEBI Listing Regulations
Corporate Actions
No Upcoming Board Meetings
Hikal Ltd has declared 10% dividend, ex-date: 17 Feb 26
Hikal Ltd has announced 2:10 stock split, ex-date: 27 Feb 15
Hikal Ltd has announced 1:2 bonus issue, ex-date: 22 Jun 18
No Rights history available







